Man Group
AMED

Man Group’s Amedisys AMED Stock Holding History

Man Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-69,198
Closed -$6.81M – 2196
2025
Q2 		$6.81M Buy
+69,198
New +$6.55M 0.01% 928
2023
Q3 		– Sell
-243,000
Closed -$22.5M – 247
2023
Q2 		$22.2M Buy
+243,000
New +$19.9M 0.07% 355
2023
Q1 		– Sell
-9,029
Closed -$781K – 1076
2022
Q4 		$754K Sell
9,029
-17,992
-67% -$1.62M ﹤0.01% 1398
2022
Q3 		$2.62M Buy
+27,021
New +$3.22M 0.01% 975
2022
Q2 		– Sell
-7,204
Closed -$920K – 1277
2022
Q1 		$1.24M Buy
7,204
+260
+4% +$38.8K ﹤0.01% 1322
2021
Q4 		$1.12M Sell
6,944
-28,301
-80% -$4.55M ﹤0.01% 1305
2021
Q3 		$5.25M Sell
35,245
-28,161
-44% -$5.85M 0.02% 813
2021
Q2 		$15.5M Buy
63,406
+29,385
+86% +$7.71M 0.05% 401
2021
Q1 		$9.01M Sell
34,021
-3,029
-8% -$854K 0.04% 460
2020
Q4 		$10.9M Sell
37,050
-7,219
-16% -$1.85M 0.05% 412
2020
Q3 		$10.5M Buy
44,269
+18
+0% +$4.09K 0.04% 455
2020
Q2 		$8.79M Sell
44,251
-69,733
-61% -$13M 0.04% 404
2020
Q1 		$20.9M Sell
113,984
-130,543
-53% -$23.2M 0.14% 152
2019
Q4 		$40.8M Sell
244,527
-31,360
-11% -$4.66M 0.13% 166
2019
Q3 		$36.1M Sell
275,887
-66,312
-19% -$8.63M 0.13% 175
2019
Q2 		$41.5M Buy
342,199
+22,842
+7% +$2.71M 0.15% 154
2019
Q1 		$39.4M Buy
319,357
+178,405
+127% +$22.4M 0.15% 149
2018
Q4 		$16.5M Sell
140,952
-15,866
-10% -$1.87M 0.07% 304
2018
Q3 		$19.6M Buy
156,818
+3,312
+2% +$366K 0.07% 330
2018
Q2 		$13.1M Buy
153,506
+22,090
+17% +$1.62M 0.05% 440
2018
Q1 		$7.93M Buy
+131,416
New +$7.49M 0.04% 595

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Man Group's AMED Position: Q3 2025 in Review

Man Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 69,198 shares — an estimated $6.81M sold.

Man Group first reported a position in AMED in Q1 2018 and held it in 21 quarters. The position peaked at $41.5M in Q2 2019. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Man Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 69,198 Amedisys shares in Q3 2025, an estimated $6.81M.
  • Man Group first reported a position in Amedisys in Q1 2018 and held it in 21 quarters.
  • Man Group's Amedisys position peaked at $41.5M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.